主动脉瓣篇章II：TAVR全生命周期管理
Lifetime Management of TAVR
04/19 10:10-12:10
主会场-开元厅A (Main Venue-Room Kaiyuan A)
-
10:10-12:10
-
10:10-12:10讨论嘉宾PanelistHemal GADA (University Of Pittsburgh Medical Center Pinnacle, USA), Jeremiah DEPTA (Rochester Regional Health, USA), Alfonso IELASI (IRCCS Ospedale Galeazzi Sant’Ambrogio, Milan, Italy), Kendra Janel GRUBB (Emory University, USA), 郭延松(GUO Yan-Song) (福建省立医院), 曾和松(ZENG He-Song) (华中科技大学同济医学院附属同济医院), 陈维(CHEN Wei) (同济大学附属上海第十人民医院), 修建成(XIU Jian-Cheng) (南方医科大学南方医院)
-
10:10-10:30TAVR患者的全生命周期管理Lifetime Management of TAVR Patients
-
10:30-10:50TAVR长期耐久性研究：瓣膜功能衰退与再介入策略TAVR Long-term Durability Study: Valve Function Decline and Reintervention Strategies
-
10:50-11:10个体化TAVR策略：如何优化瓣膜选择与植入技术Individualized TAVR Strategy: How to Optimize Valve Selection and Implantation Technique
-
11:10-11:30TAVR患者全生命周期管理中的影像学评估与并发症预测Imaging Assessment and Complication Prediction in the Lifetime Management of TAVR Patients
-
11:30-11:50TAVR后的最佳药物治疗：逆转心脏重构的新型药物Optimal Medical Therapy Post-TAVR: Novel Agents for Cardiac Reverse Remodeling
-
11:50-12:10TAVR在低危及年轻患者中的适应证扩展与长期预后Expansion of TAVR Indications and Long-term Outcomes in Low-risk Younger Patients